Publications by authors named "Shon W Lewis"

Claim this Profile
D
Development and Validation of a Nonremission Risk Prediction Model in First-Episode Psychosis: An Analysis of 2 Longitudinal Studies.
Samuel P Leighton, Rajeev Krishnadas, Rachel Upthegrove, Steven Marwaha, Ewout W Steyerberg, Shon W Lewis

Schizophr Bull Open· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of delaying treatment of first-episode psychosis on symptoms and social outcomes: a longitudinal analysis and modelling study.
Richard J Drake, Nusrat Husain, Max Marshall, Shôn W Lewis, Barbara Tomenson

Lancet Psychiatry· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study.
René S Kahn, Inge Winter van Rossum, Stefan Leucht, Philip McGuire, Shon W Lewis

Lancet Psychiatry· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapist Effects and the Impact of Early Therapeutic Alliance on Symptomatic Outcome in Chronic Fatigue Syndrome.
Lucy P Goldsmith, Graham Dunn, Richard P Bentall, Shôn W Lewis, Alison J Wearden

PLoS One· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Therapist Effects and the Impact of Early Therapeutic Alliance on Symptomatic Outcome in Chronic Fatigue Syndrome.
Lucy P Goldsmith, Graham Dunn, Richard P Bentall, Shôn W Lewis, Alison J Wearden

PLoS One· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Therapist Effects and the Impact of Early Therapeutic Alliance on Symptomatic Outcome in Chronic Fatigue Syndrome.
Lucy P Goldsmith, Graham Dunn, Richard P Bentall, Shôn W Lewis, Alison J Wearden

PLoS One· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How age and gender predict illness course in a first-episode nonaffective psychosis cohort.
Richard J Drake, Jean Addington, Ananth C Viswanathan, Shôn W Lewis, Jack Cotter

J Clin Psychiatry· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mental health research priorities for Europe.
Til Wykes, Josep Maria Haro, Stefano R Belli, Carla Obradors-Tarragó, Celso Arango, Shôn W Lewis

Lancet Psychiatry· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients' subjective rating of mental health improvement in a randomised controlled trial.
Karen P Hayhurst, Richard J Drake, Jennifer A Massie, Graham Dunn, Shôn W Lewis

Psychiatry Res· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modafinil combined with cognitive training: pharmacological augmentation of cognitive training in schizophrenia.
Panayiota G Michalopoulou, Shôn W Lewis, Richard J Drake, Abraham Reichenberg, Richard Emsley

Eur Neuropsychopharmacol· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling determinants of medication attitudes and poor adherence in early nonaffective psychosis: implications for intervention.
Richard J Drake, Merete Nordentoft, Gillian Haddock, Celso Arango, W Wolfgang Fleischhacker, Shon W Lewis

Schizophr Bull· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validity of subjective versus objective quality of life assessment in people with schizophrenia.
Karen P Hayhurst, Jennifer A Massie, Graham Dunn, Shôn W Lewis, Richard J Drake

BMC Psychiatry· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Towards Horizon 2020: challenges and advances for clinical mental health research - outcome of an expert survey.
Christina M van der Feltz-Cornelis, Jim van Os, Susanne Knappe, Gunter Schumann, Eduard Vieta, Shôn W Lewis

Neuropsychiatr Dis Treat· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The temporal association between self-injurious thoughts and psychotic symptoms: a mobile phone assessment study.
Jasper E Palmier-Claus, Peter J Taylor, John Ainsworth, Matthew Machin, Graham Dunn, Shon W Lewis

Suicide Life Threat Behav· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MRI diffusion tractography study in individuals with schizotypal features: a pilot study.
Richard P Smallman, Emma Barkus, Hojjatollah Azadbakht, Karl V Embleton, Hamied A Haroon, Shôn W Lewis

Psychiatry Res· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
ROAMER: roadmap for mental health research in Europe.
Josep Maria Haro, José Luis Ayuso-Mateos, Istvan Bitter, Jacques Demotes-Mainard, Marion Leboyer, Shôn W Lewis

Int J Methods Psychiatr Res· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of prior treatment with antipsychotic long-acting injection on randomised clinical trial treatment outcomes.
Thomas R E Barnes, Richard J Drake, Graham Dunn, Karen P Hayhurst, Peter B Jones, Shôn W Lewis

Br J Psychiatry· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treating impaired cognition in schizophrenia: the case for combining cognitive-enhancing drugs with cognitive remediation.
Panayiota G Michalopoulou, Shôn W Lewis, Til Wykes, Judith Jaeger, Shitij Kapur

Eur Neuropsychopharmacol· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-neurological and metabolic side effects in the Cost Utility of the Latest Antipsychotics in Schizophrenia Randomised Controlled Trial (CUtLASS-1).
Michael J Peluso, Shôn W Lewis, Thomas R E Barnes, Peter B Jones

Schizophr Res· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrating mobile-phone based assessment for psychosis into people's everyday lives and clinical care: a qualitative study.
Jasper E Palmier-Claus, Anne Rogers, John Ainsworth, Matt Machin, Christine Barrowclough, Shôn W Lewis

BMC Psychiatry· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The feasibility and validity of ambulatory self-report of psychotic symptoms using a smartphone software application.
Jasper E Palmier-Claus, John Ainsworth, Matthew Machin, Cristine Barrowclough, Graham Dunn, Shôn W Lewis

BMC Psychiatry· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sexual function of patients with schizophrenia receiving first-generation (FGA) or second-generation antipsychotic (SGA) treatment.
Ahmed Mahmoud, Karen P Hayhurst, Richard J Drake, Shôn W Lewis

Int J Psychiatry Clin Pract· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extrapyramidal motor side-effects of first- and second-generation antipsychotic drugs.
Michael J Peluso, Shôn W Lewis, Thomas R E Barnes, Peter B Jones

Br J Psychiatry· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early detection and intervention evaluation for people at risk of psychosis: multisite randomised controlled trial.
Anthony P Morrison, Paul French, Suzanne L K Stewart, Max Birchwood, David Fowler, Shôn W Lewis

BMJ· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The ANNSERS (Antipsychotic Non-Neurological Side Effects Rating Scale): Validation of Sexual Side-Effect Measurement.
Ahmed Mahmoud, Karen P Hayhurst, Richard J Drake, Shôn W Lewis, Thomas R E Barnes

Ther Adv Psychopharmacol· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis